To investigate role of high-dose Tirofiban. A contemporary pharmacological therapy of STEMI patients undergoing PCI.



Patients with ST-segment elevation myocardial infarction (STEMI) have high expression of platelet P2Y12 receptors and high platelet reactivity that are associated to worse clinical outcome after revascularization with primary percutaneous coronary intervention (pPCI)

Copyright © 2020 Terumo India Private limited

X
Important information regarding

By using this website, you consent to the use of cookies in accordance with our